‘In most patients with psoriatic arthritis, the symptoms do not develop until years after the onset of skin psoriasis,’ write OGDI Alexis, MD, and Joel M. ‘As a result, patients with psoriasis represents a unique opportunity to identify those at high risk of developing a chronic inflammatory arthropathy . To determine which patients with psoriasis are at increased risk of developing psoriatic arthritis, it is essential that risk factors to be identified with the sound epidemiological approaches. ‘Psoriatic arthritis is a type of arthritis that develops in the joints of some patients with psoriasis. According to information provided in this article, ‘obesity is a major risk factor for psoriasis,’ and ‘psoriatic arthritis affects 6 % to 42 % of people with psoriasis.’ Additionally, ‘psoriatic arthritis shares some clinical features of rheumatoid arthritis, both leading to joint destruction and significant morbidity.’
Razieh Soltani-Arabshahi, MD, University of Utah School of Medicine, Salt Lake City, and colleagues studied a sample of volunteer patients with psoriasis enrolled dermatologist-diagnosed psoriasis Initiative Utah from November 2002 to October 2008. Among the 943 participants, 50.5 % of participants with psoriasis .
LDR, a private medical device offering innovative spinal implants for both non-fusion and fusion applications, announced March 11 its two levels of memory Mobi-C artificial cervical disc PMA to the FDA. Following quickly on our January single-level PMA, this presentation is a two-level milestone for the LDR. And ‘the culmination of a five-year period, 600 patients, including the two arms of the study IED and an investment of over $ 25 million, said Christophe Lavigne, president and CEO of LDR. Mr. Lavigne adds: We are extremely pleased with the results of the two arms of the study and data at two levels, especially. Mobi-C investigators will present the results of the study ISASS to meet next month in Las Vegas.
The authors conclude that their results ‘support a concept more than the patients most likely to psoriatic arthritis may benefit from control measures more frequent and accurate for early diagnosis and treatment of psoriatic arthritis, c ie before the development of irreversible joint destruction. ‘
‘Using data accumulated over the years to come, future studies of risk factors could overcome the methodological challenges of previous surveys, and wait for the results.
Finally, the identification of risk factors for psoriatic arthritis is the promise of improving our ability to diagnose this condition and modification of risk factors for preventable. ‘